245 related articles for article (PubMed ID: 11139480)
1. Upregulation of the nitric oxide-cGMP pathway in aged myocardium: physiological response to l-arginine.
Zieman SJ; Gerstenblith G; Lakatta EG; Rosas GO; Vandegaer K; Ricker KM; Hare JM
Circ Res; 2001 Jan; 88(1):97-102. PubMed ID: 11139480
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
Itoh T; Haruna M; Abe K
Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of arginase I restores NO signaling in the vasculature of old rats.
White AR; Ryoo S; Li D; Champion HC; Steppan J; Wang D; Nyhan D; Shoukas AA; Hare JM; Berkowitz DE
Hypertension; 2006 Feb; 47(2):245-51. PubMed ID: 16380531
[TBL] [Abstract][Full Text] [Related]
4. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide: a trigger for classic preconditioning?
Lochner A; Marais E; Genade S; Moolman JA
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2752-65. PubMed ID: 11087230
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by activation of NO/cGMP pathway after cardioplegic arrest and 8-hour storage.
Ali IS; Gandhi M; Finegan BA; Koshal A; Clanachan AS
Ann Thorac Surg; 1998 May; 65(5):1303-9. PubMed ID: 9594856
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP as a second messenger in the nitric oxide-mediated conidiation of the mycoparasite Coniothyrium minitans.
Li B; Fu Y; Jiang D; Xie J; Cheng J; Li G; Hamid MI; Yi X
Appl Environ Microbiol; 2010 May; 76(9):2830-6. PubMed ID: 20208018
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
9. Activation of nitric oxide signaling pathway mediates hypotensive effect of Muntingia calabura L. (Tiliaceae) leaf extract.
Shih CD; Chen JJ; Lee HH
Am J Chin Med; 2006; 34(5):857-72. PubMed ID: 17080550
[TBL] [Abstract][Full Text] [Related]
10. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels.
Berkowitz DE; White R; Li D; Minhas KM; Cernetich A; Kim S; Burke S; Shoukas AA; Nyhan D; Champion HC; Hare JM
Circulation; 2003 Oct; 108(16):2000-6. PubMed ID: 14517171
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
[TBL] [Abstract][Full Text] [Related]
12. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.
Paolocci N; Ekelund UE; Isoda T; Ozaki M; Vandegaer K; Georgakopoulos D; Harrison RW; Kass DA; Hare JM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1982-8. PubMed ID: 11009488
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
14. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
[TBL] [Abstract][Full Text] [Related]
15. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347
[TBL] [Abstract][Full Text] [Related]
16. Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats.
Chan MH; Chien TH; Lee PY; Chen HH
Psychopharmacology (Berl); 2004 Nov; 176(3-4):435-9. PubMed ID: 15118807
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide production in carbachol-induced negative chronotropy in cultured rat ventricular myocytes.
Yamamoto S; Miyamoto A; Kawana S; Namiki A; Ohshika H
Eur J Pharmacol; 1999 Jan; 366(1):111-8. PubMed ID: 10064159
[TBL] [Abstract][Full Text] [Related]
18. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart.
Hare JM; Kim B; Flavahan NA; Ricker KM; Peng X; Colman L; Weiss RG; Kass DA
J Clin Invest; 1998 Mar; 101(6):1424-31. PubMed ID: 9502785
[TBL] [Abstract][Full Text] [Related]
19. L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism.
Agulló L; García-Dorado D; Inserte J; Paniagua A; Pyrhonen P; Llevadot J; Soler-Soler J
Am J Physiol; 1999 May; 276(5):H1574-80. PubMed ID: 10330241
[TBL] [Abstract][Full Text] [Related]
20. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
